Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Brushite
2. Calcium Monohydrogen Phosphate Dihydrate
3. Calcium Phosphate, Dibasic
4. Calcium Phosphate, Dibasic, Dihydrate
5. Calcium Phosphate, Dihydrate (1:1)
6. Dibasic Calcium Phosphate Dihydrate
7. Dicalcium Phosphate
8. Dicalcium Phosphate Anhydrous
9. Dicalcium Phosphate Dihydrate
1. 7789-77-7
2. Calcium Hydrogenphosphate Dihydrate
3. Dicalcium Phosphate Dihydrate
4. Calcium Monohydrogen Phosphate Dihydrate
5. 14567-92-1
6. Dibasic Calcium Phosphate Dihydrate
7. Calcium Phosphate, Dibasic, Dihydrate
8. Calciumhydrogenphosphatedihydrate
9. D.c.p.
10. Calcium Phosphate Dibasic Dihydrate
11. Calcium;hydrogen Phosphate;dihydrate
12. Calcium Phosphate Dihydrate, Dibasic
13. O7tsz97gep
14. Phosphoric Acid, Calcium Salt (1:1), Dihydrate
15. Dibasic Calcium Phosphate Hydrate
16. Calcium Phosphate Dibasic, Hydrous
17. Calcium Phosphate, Dibasic, Hydrous
18. Brushite
19. Aksepillen
20. Eunova
21. Unii-o7tsz97gep
22. Brushite (ca(hpo4).2h2o)
23. Calcium-hydrogenphosphat-2-wasser
24. Calster (tn)
25. Cahpo4.2h2o
26. Calcium Phosphate Dihydrate, Dibasic [usp:jan]
27. Calcium Phosphate, Gel (aged)
28. Chebi:4496
29. Dibasic Calcium Phosphate (tn)
30. Dtxsid90872536
31. Mfcd00149621
32. Akos015855298
33. Db14481
34. Calcium Hydrogenphosphate Dihydrate,(s)
35. Calcium Hydrogenphosphate--water (1/2)
36. Calcium Hydrogenphosphate Dihydrate, 98%
37. Dibasic Calcium Phosphate Hydrate (jp17)
38. Dicalcium Phosphate Dihydrate [inci]
39. Calcium Phosphate Dihydrate [who-dd]
40. Calcium Phosphate, Dihydrate (1:1)
41. Calcium Phosphate, Dihydrate, Dibasic (usp)
42. Ft-0623398
43. D00937
44. Dibasic Calcium Phosphate Hydrate [jan]
45. Calcium Phosphate, Dibasic, Dihydrate [ii]
46. Calcium Hydrogen Phosphate Dehydrate [who-ip]
47. Calcii Hydrogenophosphas Dihydrate [who-ip Latin]
48. Calcium Hydrogen Phosphate Dihydrate [ep Monograph]
49. Calcium Hydrogenphosphate Dihydrate, P.a., 98.0-105.0%
50. Calcium Hydrogenphosphate Dihydrate, Vetec(tm) Reagent Grade
51. Calcium Phosphate Dihydrate, Dibasic [usp Impurity]
52. Dibasic Calcium Phosphate Dihydrate [usp Monograph]
53. Calcium Phosphate Dibasic Dihydrate, Puriss., Meets Analytical Specification Of Ph. Eur., Bp, Usp, 98-102.5%
Molecular Weight | 172.09 g/mol |
---|---|
Molecular Formula | CaH5O6P |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Exact Mass | 171.9449657 g/mol |
Monoisotopic Mass | 171.9449657 g/mol |
Topological Polar Surface Area | 85.4 Ų |
Heavy Atom Count | 8 |
Formal Charge | 0 |
Complexity | 46.5 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
For use as an over the counter calcium and phosphate supplement, antacid, or a source of calcium and phosphate in toothpaste.
Calcium phosphate reacts with acid in the stomach to raise the pH. In toothpaste it provides a source of calcium and phosphate ions to support remineralization of the teeth. As a supplement it provides a source of calcium and phospate, both of which are important ions in bone homeostasis.
The phosphate ions in calcium phosphate likely react with hydrochloric acid in the stomach to neutralize the pH. In toothpaste and in systemic circulation, calcium phosphate provides a source of calcium and phosphate ions to support remineralization of the teeth and bone homeostasis respectively. The increase in plasma calcium reduces calcium flux from osteocyte activity by reducing the secretion of parathyroid hormone (PTH). Calcium does this by stimulating a G-protein coupled calcium receptor on the surface of parathyroid cells. The reduction in calcium flux increases the amount of calcium deposited in bone resulting in an increase in bone mineral density. The reduction in PTH secretion also reduces the amount of vitamin D metabolized to its active form, calcidiol. Since calcidiol increases the expression of calcium dependent ATPases and transient receptor potential cation channel subfamily V member 6 (TRPV6) both of which are involved in calcium uptake from the gut, a reduction in calcidiol results in less calcium absorption. Additionally, TRPV5, the channel responsible for calcium reabsorption in the kidney, is downregulated when PTH secretion is reduced thus increasing calcium excretion via the kidneys. Another hormone, calitonin, is likely involved in the reduction of bone resorption during periods of high plasma calcium.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37690
Submission : 2022-11-24
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40452
Submission : 2024-09-19
Status : Active
Type : IV
NDC Package Code : 84414-000
Start Marketing Date : 2024-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29479
Submission : 2015-05-28
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39811
Submission : 2024-04-03
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3064
Submission : 1977-11-04
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registration Number : 221MF10072
Registrant's Address : 305 Yashima Nishimachi, Takamatsu City, Kagawa Prefecture
Initial Date of Registration : 2009-04-08
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37690
Submission : 2022-11-24
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29479
Submission : 2015-05-28
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40452
Submission : 2024-09-19
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39811
Submission : 2024-04-03
Status : Active
Type : IV
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3064
Submission : 1977-11-04
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Japanese Pharmacopoeia Calcium Hydrogen Phosphate Hydrate (For manufacturing only)
Registration Number : 221MF10072
Registrant's Address : 305 Yashima Nishimachi, Takamatsu City, Kagawa Prefecture
Initial Date of Registration : 2009-04-08
Latest Date of Registration : 2009-04-08
DIBASIC CALCIUM PHOSPHATE DIHYDRATE
NDC Package Code : 84414-000
Start Marketing Date : 2024-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Dibasic Calcium Phosphate Dihydrate
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Dibasic Calcium Phosphate Dihydrate
About the Company : Nitika Pharmaceutical Specialities was found in 1991 as a small manufacturing unit has grown today into a dynamic production center for a range of products finding applications in ...
Calcium hydrogen phosphate dihydrate
About the Company : Sudeep Pharma Pvt. Ltd. is a leading producer of Calcium based Pharmaceutical, Food and Feed ingredients in India for the last quarter of a century. Established in 1989, we are one...
Related Excipient Companies
Dosage Form : Granule / Pellet
Grade : Not Available
Brand Name : Kollicoat SR 30 D
Application : Taste Masking
Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.
Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Hydrated Silica
Dosage Form : Emulsion
Grade : Not Available
Application : Topical
Excipient Details : Self-emulsifying and consistency building, easy-to-use base for dermatological creams
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : Wetting agent, reduces disintegration time, Ionic solubilizer, high HLB anionic emulsifier for semi-solids and foams.
Pharmacopoeia Ref : Ph. Eur.: Sodium Laurilsulfate...
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Tablet
Grade : Not Available
Brand Name : Kolliphor SLS Fine
Application : Granulation
Excipient Details : Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.
Pharmacopoeia Ref : Ph. Eur.: Sodium Laurilsulfate...
Technical Specs : Not Available
Ingredient(s) : Sodium Lauryl Sulfate
Dosage Form : Gel
Grade : Not Available
Brand Name : Kollisolv PEG 1000
Application : Topical
Excipient Details : Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG
Dosage Form : Suppository
Grade : Not Available
Brand Name : Kollisolv PEG 1450
Application : Thickeners and Stabilizers
Excipient Details : Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG
Dosage Form : Emulsion
Grade : Not Available
Brand Name : Kollisolv PEG 300
Application : Solubilizers
Excipient Details : Liquid plasticizer, solvent for oral and topical applications, hydrophilic fill for solubilization of hydrophilic APIs.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 300
Dosage Form : Tablet
Grade : Not Available
Brand Name : Kollisolv PEG 400
Application : Solubilizers
Excipient Details : Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 400
Dosage Form : Softgel Capsule
Grade : Not Available
Brand Name : Kollisolv PEG 600
Application : Solubilizers
Excipient Details : Hydrophilic fill for solubilization of hydrophilic APIs.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 600
Excipients by Applications
Market Place
ABOUT THIS PAGE
A Dibasic Calcium Phosphate Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dibasic Calcium Phosphate Dihydrate, including repackagers and relabelers. The FDA regulates Dibasic Calcium Phosphate Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dibasic Calcium Phosphate Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dibasic Calcium Phosphate Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dibasic Calcium Phosphate Dihydrate supplier is an individual or a company that provides Dibasic Calcium Phosphate Dihydrate active pharmaceutical ingredient (API) or Dibasic Calcium Phosphate Dihydrate finished formulations upon request. The Dibasic Calcium Phosphate Dihydrate suppliers may include Dibasic Calcium Phosphate Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Dibasic Calcium Phosphate Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dibasic Calcium Phosphate Dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dibasic Calcium Phosphate Dihydrate active pharmaceutical ingredient (API) in detail. Different forms of Dibasic Calcium Phosphate Dihydrate DMFs exist exist since differing nations have different regulations, such as Dibasic Calcium Phosphate Dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dibasic Calcium Phosphate Dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Dibasic Calcium Phosphate Dihydrate USDMF includes data on Dibasic Calcium Phosphate Dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dibasic Calcium Phosphate Dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dibasic Calcium Phosphate Dihydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dibasic Calcium Phosphate Dihydrate Drug Master File in Japan (Dibasic Calcium Phosphate Dihydrate JDMF) empowers Dibasic Calcium Phosphate Dihydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dibasic Calcium Phosphate Dihydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Dibasic Calcium Phosphate Dihydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dibasic Calcium Phosphate Dihydrate suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dibasic Calcium Phosphate Dihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dibasic Calcium Phosphate Dihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dibasic Calcium Phosphate Dihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dibasic Calcium Phosphate Dihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dibasic Calcium Phosphate Dihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dibasic Calcium Phosphate Dihydrate suppliers with NDC on PharmaCompass.
Dibasic Calcium Phosphate Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dibasic Calcium Phosphate Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dibasic Calcium Phosphate Dihydrate GMP manufacturer or Dibasic Calcium Phosphate Dihydrate GMP API supplier for your needs.
A Dibasic Calcium Phosphate Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Dibasic Calcium Phosphate Dihydrate's compliance with Dibasic Calcium Phosphate Dihydrate specifications and serves as a tool for batch-level quality control.
Dibasic Calcium Phosphate Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Dibasic Calcium Phosphate Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dibasic Calcium Phosphate Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dibasic Calcium Phosphate Dihydrate EP), Dibasic Calcium Phosphate Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dibasic Calcium Phosphate Dihydrate USP).
LOOKING FOR A SUPPLIER?